Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
657 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02503111 | The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men(HPV-SAVE) | terminated | N/A | 71 | University Health Network, TorontoOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03947775 | HPV-SAVE_Merck_Sub-Study for Preventing Recurrence of HSIL | unknown | Phase 2 | 228 | University Health Network, TorontoOTHER | 1 | Jun 13, 2022 | clinicaltrials |
| NCT03987906 | Symptom Screening With Targeted Early Palliative Care (STEP) Versus Usual Care for Patients With Advanced Cancer(STEP) | terminated | N/A | 69 | University Health Network, TorontoOTHER | 1 | May 23, 2022 | clinicaltrials |
| NCT04606940 | Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN) | completed | — | 18 | University Health Network, TorontoOTHER | 1 | May 19, 2022 | clinicaltrials |
| NCT04193657 | Toward a Comprehensive Supportive Care Intervention for Older or Frail Men With mCRPC(TOPCOP2) | completed | — | 91 | University Health Network, TorontoOTHER | 1 | May 18, 2022 | clinicaltrials |
| NCT02494791 | Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer(LS2) | unknown | N/A | 886 | University Health Network, TorontoOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT03558165 | Lung Cancer Next Generation Sequencing Using the Oncomine Comprehensive Assay(LU-NGS-2) | completed | — | 134 | University Health Network, TorontoOTHER | 1 | May 17, 2022 | clinicaltrials |
| NCT02399943 | A Trial of Trametinib and Panitumumab in RAS/RAF Wild Type Advanced Colorectal Cancer | completed | Phase 2 | 14 | University Health Network, TorontoOTHER | 1 | May 16, 2022 | clinicaltrials |
| NCT02952521 | Ovarian Tumor Biopsies to Study Response to Treatments | completed | — | 5 | University Health Network, TorontoOTHER | 1 | May 10, 2022 | clinicaltrials |
| NCT02681237 | A Study of Cediranib and Olaparib at Disease Worsening in Ovarian Cancer | completed | N/A | 34 | University Health Network, TorontoOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT03410446 | Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care | completed | Phase 2 | 22 | University Health Network, TorontoOTHER | 1 | May 6, 2022 | clinicaltrials |
| NCT03266900 | A Superiority Trial to Compare Re-resection of High-grade T1 Bladder Urothelial Carcinoma to no Re-resection for Improving Progression Free Survival(RESECT) | terminated | Early Phase 1 | 2 | University Health Network, TorontoOTHER | 1 | Apr 20, 2022 | clinicaltrials |
| NCT02586844 | Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors(NET-SEQ) | completed | — | 13 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03390569 | Exercise in Patients With Glioblastoma | completed | N/A | 54 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT05260788 | Mapping 3D Bladder | withdrawn | — | 0 | University Health Network, TorontoOTHER | 1 | Apr 14, 2022 | clinicaltrials |
| NCT03396705 | Liver Regeneration | terminated | — | 2 | University Health Network, TorontoOTHER | 1 | Apr 7, 2022 | clinicaltrials |
| NCT03186404 | Statins for the Primary Prevention of Heart Failure in Patients Receiving Anthracycline Pilot Study(SPARE-HF) | unknown | Phase 2 | 112 | University Health Network, TorontoOTHER | 1 | Feb 8, 2022 | clinicaltrials |
| NCT05193253 | Long-term Outcomes of Ablation, Liver Resection, and Liver Transplant as First-line Treatment for Solitary HCC of 3 cm or Less | completed | — | 119 | University Health Network, TorontoOTHER | 0 | Jan 18, 2022 | clinicaltrials |
| NCT03042819 | Study of Selinexor and Doxorubicin in Advanced Soft Tissue Sarcomas | completed | Phase 1 | 25 | University Health Network, TorontoOTHER | 1 | Dec 9, 2021 | clinicaltrials |
| NCT03520231 | Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases | completed | Phase 2 | 6 | University Health Network, TorontoOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT01334086 | Aprepitant as Antiemetic Prophylaxis in Patients With Acute Myeloid Leukemia Undergoing Induction Chemotherapy | completed | Phase 2 | 41 | University Health Network, TorontoOTHER | 1 | Nov 22, 2021 | clinicaltrials |
| NCT03235934 | Glycemic Impact on Glioblastoma Outcomes | withdrawn | — | 0 | University Health Network, TorontoOTHER | 1 | Oct 25, 2021 | clinicaltrials |
| NCT00892658 | Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP) | completed | Phase 1 | 24 | University Health Network, TorontoOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT00914355 | Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2) | completed | Phase 2 | 92 | University Health Network, TorontoOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT00914615 | Stereotactic Body Radiation Therapy (SBRT) in Liver Metastasis (COLD 3) | completed | Phase 2 | 35 | University Health Network, TorontoOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT01480973 | Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer | completed | N/A | 30 | University Health Network, TorontoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT03048435 | Cervical Ca PROs in Clinical Practice | completed | — | 100 | University Health Network, TorontoOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT03849950 | Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare) | terminated | N/A | 62 | University Health Network, TorontoOTHER | 1 | Sep 30, 2021 | clinicaltrials |
| NCT03335631 | Preference-Based Exercise RCT for Men With PC on ADT(PBExRCT) | completed | N/A | 56 | University Health Network, TorontoOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT03672799 | Rehabilitation Planning Consult Phase II Trial(RPC-II) | completed | N/A | 153 | University Health Network, TorontoOTHER | 1 | Jul 13, 2021 | clinicaltrials |
| NCT00087165 | GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer | completed | Phase 2 | 22 | University Health Network, TorontoOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT02472249 | Pharmacological Manipulation of Intrahepatic Arterial Blood Flow in HCC | completed | Phase 4 | 10 | University Health Network, TorontoOTHER | 1 | Apr 28, 2021 | clinicaltrials |
| NCT02394652 | The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial | completed | Phase 2 | 16 | University Health Network, TorontoOTHER | 1 | Apr 21, 2021 | clinicaltrials |
| NCT02497638 | LIpitor and biGuanide to Androgen Delay Trial(LIGAND) | withdrawn | Phase 2 | 0 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT02537223 | Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer | completed | Phase 1 | 9 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03342677 | Evaluation of Gd-EOB-DTPA MRI for Detection and Characterization of Liver Nodules in Cirrhotic Patients Undergoing Liver Transplantation and Potential Impact on Transplant Eligibility | unknown | N/A | 80 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03352037 | 18F-FDG PET/MR Imaging for Differentiation of Serous From Non-Serous Pancreatic Cystic Neoplasms: A Pilot Study | completed | N/A | 11 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03460028 | Yoga for Persistent Pain Related to Oncology Surgery | completed | N/A | 23 | University Health Network, TorontoOTHER | 1 | Apr 19, 2021 | clinicaltrials |
| NCT03396848 | Sexual Health and Rehabilitation eClinic (SHAReClinic) | unknown | N/A | 65 | University Health Network, TorontoOTHER | 1 | Apr 14, 2021 | clinicaltrials |
| NCT02046837 | An Exercise Trial and Economic Analysis in Men With Prostate Cancer(ADT Ex RCT) | completed | Phase 2 | 59 | University Health Network, TorontoOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT02812589 | Diffusion Tensor Breast MRI (DTI) | completed | N/A | 267 | University Health Network, TorontoOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT02834416 | ADT Exercise Trial and Economic Analysis(ADTExRCT) | completed | Phase 3 | 38 | University Health Network, TorontoOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT02911649 | Reducing Sedentary Behaviour With Technology | completed | N/A | 28 | University Health Network, TorontoOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT03442478 | Comparison of Digital Breast Tomosynthesis to Conventional Mammography | completed | N/A | 100 | University Health Network, TorontoOTHER | 1 | Apr 13, 2021 | clinicaltrials |
| NCT01692600 | Optical Coherence Tomography for Monitoring Late Oral Radiation Toxicity After Radiotherapy of Head and Neck Cancer Patients | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Apr 5, 2021 | clinicaltrials |
| NCT03081702 | A Study of the Safety, Tolerability and Effectiveness of Hydroxychloroquine and Itraconazole in Platinum-resistant Epithelial Ovarian Cancer | completed | Phase 1 / Phase 2 | 13 | University Health Network, TorontoOTHER | 1 | Apr 2, 2021 | clinicaltrials |
| NCT02811497 | Study of Azacitidine and Durvalumab in Advanced Solid Tumors(METADUR) | completed | Phase 2 | 28 | University Health Network, TorontoOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT03419247 | Molecular Profiling of Advanced Biliary Tract Cancers | withdrawn | N/A | 0 | University Health Network, TorontoOTHER | 0 | Apr 1, 2021 | clinicaltrials |
| NCT03938376 | Micro-Ultrasound/Magnetic Resonance Imaging 001 | completed | — | 100 | University Health Network, TorontoOTHER | 1 | Apr 1, 2021 | clinicaltrials |
| NCT01748500 | Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 21 | University Health Network, TorontoOTHER | 1 | Mar 23, 2021 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials